132 related articles for article (PubMed ID: 22154361)
1. Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin.
Peled E; Rovitsky A; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2012 Jul; 130(1):129-34. PubMed ID: 22154361
[TBL] [Abstract][Full Text] [Related]
2. An assay to evaluate heparanase procoagulant activity.
Nadir Y; Kenig Y; Drugan A; Shafat I; Brenner B
Thromb Res; 2011 Oct; 128(4):e3-8. PubMed ID: 21481923
[TBL] [Abstract][Full Text] [Related]
3. Heparanase procoagulant activity.
Nadir Y; Brenner B
Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery.
Akanmu AS; Nnodu OE; Giwa SO; Salako LA; Akinsete I; Adebule GT; Adekoya-Cole TO; Odunubi OO
Afr J Med Med Sci; 2004 Dec; 33(4):335-40. PubMed ID: 15977441
[TBL] [Abstract][Full Text] [Related]
5. Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses.
Nadir Y; Saharov G; Hoffman R; Keren-Politansky A; Tzoran I; Brenner B; Shochat T
Ann Hematol; 2015 Jul; 94(7):1213-9. PubMed ID: 25743687
[TBL] [Abstract][Full Text] [Related]
6. Heparanase procoagulant activity is elevated in women using oral contraceptives.
Matan M; Axelman E; Brenner B; Nadir Y
Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
[TBL] [Abstract][Full Text] [Related]
7. Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients.
Nadir Y; Sarig G; Axelman E; Meir A; Wollner M; Shafat I; Hoffman R; Brenner B; Vlodavsky I; Haim N
Thromb Res; 2014 Sep; 134(3):639-42. PubMed ID: 25065557
[TBL] [Abstract][Full Text] [Related]
8. Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
Virtanen L; Salmela B; Leinonen J; Lemponen M; Huhtala J; Joutsi-Korhonen L; Lassila R
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):597-603. PubMed ID: 24732174
[TBL] [Abstract][Full Text] [Related]
9. Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation.
Peled E; Melamed E; Portal TB; Axelman E; Norman D; Brenner B; Nadir Y
Thromb Res; 2016 Mar; 139():148-53. PubMed ID: 26916313
[TBL] [Abstract][Full Text] [Related]
10. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
Tran AH; Lee G
Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
[TBL] [Abstract][Full Text] [Related]
11. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Andersen JC
Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
[TBL] [Abstract][Full Text] [Related]
12. The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation.
Green L; Lawrie AS; Patel S; Hossain F; Chitolie A; Mackie IJ; Haddad FS; Machin SJ
Br J Haematol; 2010 Dec; 151(5):469-76. PubMed ID: 20950405
[TBL] [Abstract][Full Text] [Related]
13. Heparanase procoagulant effects and inhibition by heparins.
Nadir Y; Brenner B
Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
[TBL] [Abstract][Full Text] [Related]
14. Novel peptides that inhibit heparanase activation of the coagulation system.
Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
[TBL] [Abstract][Full Text] [Related]
15. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
Biagini D; Filippucci E; Agnelli G; Pagliaricci S
Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the heparanase procoagulant domain in bleeding and wound healing.
Crispel Y; Ghanem S; Attias J; Kogan I; Brenner B; Nadir Y
J Thromb Haemost; 2017 Jul; 15(7):1463-1472. PubMed ID: 28439967
[TBL] [Abstract][Full Text] [Related]
17. Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin.
Maurice-Dror C; Litvak M; Keren-Politansky A; Ackerman S; Haim N; Nadir Y
J Thromb Thrombolysis; 2020 Jul; 50(1):112-122. PubMed ID: 32377957
[TBL] [Abstract][Full Text] [Related]
18. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients.
Vincent PD; Albert M; Champagne MC; Zikos T; Boulanger I; Blais L; Williamson DR
J Crit Care; 2011 Aug; 26(4):347-51. PubMed ID: 21454037
[TBL] [Abstract][Full Text] [Related]
20. [Venous thromboembolism prophylaxis after total hip arthroplasty].
Kučera T; Malý R; Urban K; Sponer P
Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
